Statistics
Publications
41
Citations
1.5K
H-Index
23
Active since
1951
Affiliations
University of Iowa(Current)
J R Johnson is an author at University of Iowa specializing in medicine, life sciences, and oncology.
Publications per year
1951–2021
41
41
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC
Mark Agulnik, Ziehr, J R Johnson · OncoTargets and Therapy · 2013 · 117 citations · Full text
Medicine, Oncology, Pharmacology +15
Maternal obesity and pregnancy.
J R Johnson, Kolberg Bh, Michael W. Varner et al. · PubMed · 1987 · 113 citations
1–5 of 41